Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Meningeal Carcinomatosis × XL647 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Brain Neoplasms 3 Meningeal Carcinomatosis 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

trastuzumab deruxtecan 1 omburtamab I-131 1 merphos 1 epothilone B 1 adavosertib 1 XL647 1 Transplantation, Autologous 1 Sorafenib 1 Rituximab 1 Radiotherapy 1 Radiation 1 Nivolumab 1 Methotrexate 1 Ipilimumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02616393 2022-03-16

Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases

Kadmon Corporation, LLC

Phase 2 Completed

36 enrolled 22 charts

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡